Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia
Tóm tắt
Từ khóa
Tài liệu tham khảo
World Health Organization. COVID-19 Public Health Emergency of International Concern (PHEIC) global research and innovation forum. 2020 (https://www.who.int/publications/m/item/covid-19-public-health-emergency-of-international-concern-(pheic)-global-research-and-innovation-forum).
Centers for Disease Control and Prevention. Cases data and surveillance — COVID-19 hospitalization and death by race/ethnicity November 30 2020. (https://www.cdc.gov/coronavirus/2019-ncov/covid-data/investigations-discovery/hospitalization-death-by-race-ethnicity.html).
Zhu J, Pang J, Ji P, et al. Elevated interleukin-6 is associated with severity of COVID-19: a meta-analysis. J Med Virol 2020 May 29 (Epub ahead of print).32470146
Actemra prescribing information. South San Francisco CA: Genentech 2019 (package insert).
RoActemra summary of product characteristics. Grenzach-Wyhlen Germany: Roche 2020.
Rosas I Bräu N Waters M et al. Tocilizumab in hospitalized patients with COVID-19 pneumonia. September 12 2020 (https://www.medrxiv.org/content/10.1101/2020.08.27.20183442v2). preprint.
Department of Health and Human Services. Social determinants of health. 2020 (https://www.healthypeople.gov/2020/topics-objectives/topic/social-determinants-of-health).
Centers for Medicare & Medicaid Services. COVID-19 frequently asked questions (FAQs) on Medicare fee-for-service (FFS) billing. 2019 (https://www.cms.gov/files/document/03092020-covid-19-faqs-508.pdf).
National Institutes of Health. Coronavirus disease 2019 (COVID-19) treatment guidelines. 2020 (https://www.covid19treatmentguidelines.nih.gov/).
